InChI=1S/C26H32O2/c1- 19- 11- 13- 23(14- 12- 19) 22(10- 6- 8- 20(2) 18- 25(27) 28) 15- 16- 24- 21(3) 9- 7- 17- 26(24,4) 5/h6,8,10- 16,18H,7,9,17H2,1- 5H3,(H,27,28) /b8- 6+,16- 15+,20- 18+,22- 10-![](images/invisible_space.gif) |
RQANARBNMTXCDM-DKOHIBGUSA-N |
C\C(\C=C\C=C(\C=C\C1=C(C)CCCC1(C)C)/C1=CC=C(C)C=C1)=C/C(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
AP-1 antagonist
An antogonist that interferes with the action of activator protein 1 (AP-1).
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(2E,4E,6Z,8E)- 3- methyl- 7- (4- methylphenyl)- 9- (2,6,6- trimethylcyclohex- 1- en- 1- yl)nona- 2,4,6,8- tetraenoic acid
|
(2E,4E,6Z,8E)- 3- methyl- 7- (p- tolyl)- 9- (2,6,6- trimethylcyclohex- 1- en- 1- yl)nona- 2,4,6,8- tetraenoic acid
|
ChEBI
|
(E,E,Z,E)- 3- methyl- 7- (4- methylphenyl)- 9- (2,6,6- trimethyl- 1- cyclohexen- 1- yl)- 2,4,6,8- nonatetraenoic acid
|
SUBMITTER
|
SR 11302
|
SUBMITTER
|
SR-11303
|
ChEBI
|
160162-42-5
|
CAS Registry Number
|
SUBMITTER
|
21515313
|
PubMed citation
|
Europe PMC
|
23760290
|
PubMed citation
|
Europe PMC
|
24587316
|
PubMed citation
|
Europe PMC
|
24831826
|
PubMed citation
|
Europe PMC
|
25001622
|
PubMed citation
|
Europe PMC
|
26908177
|
PubMed citation
|
Europe PMC
|
27490694
|
PubMed citation
|
Europe PMC
|
29177791
|
PubMed citation
|
Europe PMC
|
31392841
|
PubMed citation
|
Europe PMC
|
33119185
|
PubMed citation
|
Europe PMC
|
33794365
|
PubMed citation
|
Europe PMC
|
35559742
|
PubMed citation
|
Europe PMC
|
35966011
|
PubMed citation
|
Europe PMC
|
36035373
|
PubMed citation
|
Europe PMC
|
36670963
|
PubMed citation
|
Europe PMC
|
36898276
|
PubMed citation
|
Europe PMC
|
37707834
|
PubMed citation
|
Europe PMC
|
9159159
|
PubMed citation
|
Europe PMC
|
|